Top Markets
#1 Official Trump Official Trump +42.55%
#2 Melania Meme Melania Meme +20.32%
#3 EXOD EXOD +18.93%
#4 Movement Movement +18.82%
#5 Mubarak Mubarak +18.55%
#6 Wrapped POL Wrapped POL +17.43%
#7 POL (ex-MATIC) POL (ex-MATIC) +17.16%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +16.13%
#9 Unit Pump Unit Pump +11.46%
#10 Pump.fun Pump.fun +11.46%
Coin of the day
Official Trump Official Trump
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
MaaT Pharma S.A. MaaT Pharma S.A.

MaaT Pharma S.A.

MAAT
Classement en actions #23616
MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on... MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on the discovery and advancement of microbiome-based biotherapies, primarily for the treatment of solid cancer tumors. Its development pipeline features MaaT013, which has successfully completed Phase 2 clinical trials for acute graft-versus-host disease (aGVHD) and is also undergoing preclinical evaluation for melanoma. Another therapeutic candidate, MaaT033, is currently in Phase 1b clinical trials, aiming to improve survival outcomes for patients with acute myeloid leukemia (AML) or other liquid malignancies following allogeneic hematopoietic stem cell transplantation. Furthermore, MaaT03X is being developed specifically for solid tumor applications. The company was founded in 2014 and maintains its headquarters in Lyon, France.
Prix de l'action
$3.78
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$71.20M
Changement (1 jour)
2.24%
Changement (1 an)
-43.37%
Pays
FR
Échange MaaT Pharma S.A. (MAAT)

Catégorie

Healthcare
Ratio P/B pour MaaT Pharma S.A. (MAAT)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de MaaT Pharma S.A., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour MaaT Pharma S.A. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH